Skip to main content

Bone Development

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Adequate Calcium TodayN/A1 trial
Active Trials
NCT02202889Completed848Est. Sep 2004
Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
Soft Tissue and Bone Development in Young GirlsN/A1 trial
Active Trials
NCT02654262Unknown450Est. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesSoft Tissue and Bone Development in Young Girls
Purdue PharmaAdequate Calcium Today

Clinical Trials (2)

Total enrollment: 1,298 patients across 2 trials

NCT02654262Human BioSciencesSoft Tissue and Bone Development in Young Girls

Soft Tissue and Bone Development in Young Girls

Start: Jan 2013Est. completion: Dec 2017450 patients
N/AUnknown
NCT02202889Purdue PharmaAdequate Calcium Today

Improving Bone Health in Adolescence Through Targeted Behavioral Intervention

Start: Sep 2000Est. completion: Sep 2004848 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.